Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Financials
Filter     Order     Display # 
Date Item Title Hits
19 Aug 2010 Achillion Pharmaceuticals, Inc. Finds $50.1M 141
19 Aug 2010 Complete Genomics, Inc. Announces Completion of $39 Million Series E Financing and Addresses Illumina, Inc. (ILMN) Patent Infringement Lawsuit 131
16 Aug 2010 AIBioTech Awarded $21 Million Government Contract 72
16 Aug 2010 ARYx Therapeutics, Inc. Secures Interim Financing of $6.3 Million; Should Allow ARYx To Operate Through End of 2010 78
14 Mar 2010 Biologics Sales 2009: Antibodies are the growth drivers 1080
04 Mar 2010 Fourth quarter and full year report 2009 - Lundbeck delivers 22 percent revenue growth for 2009 and meets financial expectations for 2009 449
02 Mar 2010 UCB: Solid foundation for sustainable growth 512
01 Mar 2010 Nycomed on track in 2009 455
26 Feb 2010 Bayer successful in a difficult environment 354
25 Feb 2010 Almirall: Solid performance in 2009, setting basis for sustainable long-term growth 674
24 Feb 2010 Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 369
24 Feb 2010 OSI Pharmaceuticals, Inc. Announces Year End 2009 Financial Results 370
24 Feb 2010 BioMarin Announces Fourth Quarter and Full Year 2009 Financial Results 420
23 Feb 2010 FY2009: Merck KGaA Revenues Increase by 2.1% to EURO 7.7 Billion 12
19 Feb 2010 Excellent results in a transformational year for Shire; core product sales up 25% 387
18 Feb 2010 Regeneron Reports Full Year and Fourth Quarter 2009 Financial and Operating Results 103
18 Feb 2010 SOLVAY : Operating result in the fourth quarter (EUR 313 million) clearly improved compared to last year (EUR 125 million) in every sector of activity; for the year overall, the decrease was limited to 6% 390
18 Feb 2010 Actelion announces Full year 2009 financial results 627
18 Feb 2010 Pharming Announces 2009 Results 389
18 Feb 2010 Biovitrum Full Year Report 2009 420
17 Feb 2010 Genzyme Reports Financial Results for Fourth Quarter of 2009 and Full Year 263
17 Feb 2010 InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 354
17 Feb 2010 Dyax Corp. Announces Fourth Quarter and Year End 2009 Financial Results 357
16 Feb 2010 Merck Announces Fourth-Quarter and Full-Year 2009 Financial Results 428
16 Feb 2010 Teva Reports Record Full Year 2009 And Fourth Quarter Results 399
11 Feb 2010 Alcon's Fourth Quarter Sales Rise 14.5 Percent 390
11 Feb 2010 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 421
11 Feb 2010 Alexion Reports Fourth Quarter and Full Year 2009 Results 414
11 Feb 2010 Cephalon Reports Record Sales and Adjusted Net Income for 2009 407
10 Feb 2010 Sanofi-aventis delivers double-digit EPS1 growth in 2009 as the Transformation program progresses 171
 
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>
Results 1 - 30 of 183

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease

Order Now

Recommended Report

R&D Drug Pipeline Database
Order Now

Subscribe La Merie Biologics